Akebia Therapeutics | AKBA - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.18B 4.3B 2026-03
Akebia Therapeutics 362.52M 357.69M 2026-03
Alnylam Pharmaceuticals USD 69.29M 60.05M 2026-03
Amgen USD 657M 4M 2026-03
Ardelyx USD 5.76M 37K 2025-12
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 484M 181M 2025-12
Bayer EUR 675M 87M 2025-12
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Celltrion KRW 19B 1.96B 2025-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Exelixis USD 23.4M 3.9M 2023-09
Fresenius Medical Care EUR 79M 6M 2026-03
GlaxoSmithKline GBP 167M 21M 2026-03
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
J&J USD 43M 25M 2026-03
Kangmei Pharma CNY 1.82M 150K 2025-09
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Medical Developments International AUD 18K 3K 2025-06
Moderna USD 11.49B 36B 2026-03
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Neuren Pharmaceuticals AUD 0 0 2024-06
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pharma Mar EUR 117K 1.24M 2025-09
Prothena USD 349.89M 347.27M 2026-03
PTC Therapeutics USD 2.87B 2.82B 2026-03
Qiagen NV USD 10.14M 1.92M 2025-12
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 178M 203M 2026-03
Sarepta Therapeutics USD 20.84M 13.28M 2025-12
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Vanda Pharmaceuticals -1.37B 1.97B 2025-12
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06